Future studies should thus: 1) Determine SorCS3 binding partners in amyloidogenic pathways and synaptic events, and 2) describe the molecular mechanisms by which SorCS3 regulates synaptic transmission in the healthy and AD brain. Here, SORCS3 is linked to Alzheimer disease.